Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
David Bronson, MD, is President of the Cleveland Clinic Regional Hospitals and serves as a member of the Executive Management Team. He also practices internal medicine on the main campus of the Cleveland Clinic.
Dr. Bronson received his undergraduate degree from the University of Maine, his MD degree from the University of Vermont, and completed residencies in internal medicine at the University of Wisconsin and the University of Vermont, where he served as Chief Resident.
He is Chairman of the Board of Governors of the American College of Physicians, and serves as Treasurer of the Board of Directors of the American Medical Association. He has published and presented papers in the areas of preoperative assessment, quality improvement, smoking cessation, predictive instruments, practice management and patient satisfaction.
Dr. Bronson has been with Cleveland Clinic since 1992 where he served as Chairman of the Department of General Internal Medicine prior to chairing the Division of Medical Regional Practice from 1995-2007. Before 1992, he was an Associate Professor of Medicine and Associate Chairman of the Department of Medicine at the University of Vermont.
The Cleveland Clinic Medicine Institute includes 220 internists, family physicians, hospitalist, geriatricians and infectious disease specialists practicing at the Cleveland Clinic Main Campus and 14 suburban practice locations in Greater Cleveland.
Specialty Interests
Consultation, Diabetes, hyperlipidemia, hypertension
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the
pharmaceutical or medical device industries to help develop medical
breakthroughs or provide medical expertise or education. Cleveland Clinic
strives to make scientific advances that will benefit patient care and
support outside relationships that promise public benefit. In order for
the discoveries of Cleveland Clinic physicians' and scientists'
laboratories and investigations to benefit the public, these discoveries
must be commercialized in partnership with industry. As experts in their
fields, Cleveland Clinic physicians and scientists are often sought after
by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters,
Cleveland Clinic maintains a program that reviews these collaborations
and, when appropriate, puts measures in place to minimize bias that may
result from ties to industry. The Cleveland Clinic publicly discloses
the names of companies when (i) its physicians/scientists receive $5,000
or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its
physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its
physicians/scientists hold any equity interest for the
physician's/scientist's role as inventor, discoverer, developer, founder
or consultant.* In publicly disclosing this information, the Cleveland
Clinic tries to provide information as accurately as possible about its
physicians' and scientists' connections with industry.
As of 3/3/2010, Dr. Bronson has reported no financial relationship
with industry that is applicable to this listing. In general, patients
should feel free to contact their doctor about any of the relationships
and how the relationships are overseen by the Cleveland Clinic. To learn
more about the Cleveland Clinic's policies on collaborations with industry
and innovation management, go to our
Integrity in Innovation
page.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
